Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-2pzkn Total loading time: 0 Render date: 2024-04-30T20:08:46.477Z Has data issue: false hasContentIssue false

11 - T lymphocyte subsets in relation to autoimmune disease

Published online by Cambridge University Press:  06 September 2009

J. S. H. Gaston
Affiliation:
University of Cambridge
Get access

Summary

Introduction

The immune system has evolved a wide variety of potent mechanisms for the elimination of pathogens. As these mechanisms are potentially damaging to the host, an essential feature of the adaptive immune response is that it should be able to distinguish self from non-self and respond, when appropriate, only to the latter. The failure of the immune system to make this distinction can result in autoreactive cells mounting immune responses against self tissues, causing life-threatening pathology. There are now an increasing number of diseases in which an autoimmune process has been implicated in the pathogenesis, including RA, insulin-dependent diabetes mellitus (IDDM), multiple sclerosis, thyrotoxicosis, systemic lupus erythematosus (SLE), autoimmune haemolytic anaemia and myasthenia gravis to name a few. In order to avoid the damaging reactions that can cause this type of disease, the immune system has evolved a number of strategies for preventing autoreactive cells from making responses against host tissues, thus maintaining a state of self-tolerance.

In broad terms, mechanisms of self-tolerance can be categorized into two different classes. In the first, tolerance is maintained by both intra- and extrathymic mechanisms. Autoreactive T cells that encounter self-antigen within the thymus are clonally deleted (Kappler, Roehm & Marrack, 1987) while autoreactive cells that escape this process are either rendered anergic (Mueller, Jenkins & Schwartz, 1989), a state thought to result from the non-immunogenic presentation of self-antigens, or simply fail to respond to self-antigens, a state known as clonal indifference (Ohashi et al., 1991).

Type
Chapter
Information
Rheumatic Diseases
Immunological Mechanisms and Prospects for New Therapies
, pp. 225 - 244
Publisher: Cambridge University Press
Print publication year: 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×